Recent article co-published by ISARIC member Jordi Rello, Clinical Research/epidemiology In Pneumonia & Sepsis (CRIPS).
Please note that we do emphasise that treatment outside of a trial environment is dangerous and unjustified.
Also By
ISARIC
- Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
- What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? - A harmonised, global longitudinal observational study
- An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a rando
Please Sign in (or Register) to view further.